Prophylactic effect of intravenous nicorandil on perioperative myocardial damage in patients undergoing off-pump coronary artery bypass surgery

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 4, 2004, Pages 501-506

  Ito, Isao ^a   Hayashi, Yukio ^a   Kawai, Yusuke ^a   Kamibayashi, Takahiko ^a   Matsumiya, Goro ^a   Takahashi, Toshiki ^a   Matsuda, Hikaru ^a   Mashimo, Takashi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Myocardial protection; Nicorandil; Off pump coronary artery bypass grafting

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; NICORANDIL; POTASSIUM CHANNEL AFFECTING AGENT; TROPONIN T;

ADULT; AGED; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MALE; OFF PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS;

AGED; BIOLOGICAL MARKERS; CARRIER PROTEINS; CORONARY ARTERY BYPASS, OFF-PUMP; CREATINE KINASE; CREATINE KINASE, MB FORM; FATTY ACID-BINDING PROTEINS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NICORANDIL; PERIOPERATIVE CARE; POSTOPERATIVE PERIOD; POTASSIUM CHANNELS; TROPONIN T;

EID: 4644256734     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000141476.52125.5b     Document Type: Article

References (25)

1. Caputo M, Yeatman M, Narayan P, et al. Effect of off-pump coronary surgery with right ventricular assist device on organ function and inflammatory response: A randomized controlled trial. Ann Thorac Surg. 2002; 74:2088-2096.
2. Masuda M, Morita S, Tomita H, et al. Off-pump CABG attenuates myocardial enzyme leakage but not postoperative brain natriuretic peptide secretion. Ann Thorac Cardiovasc Surg. 2002;8:139-144.
3. Bennetts JS, Baker RA, Ross IK, et al. Assessment of myocardial injury by troponin T in off-pump coronary artery grafting and conventional coronary artery graft surgery. ANZ J Surg. 2002;72:105-109.
4. Yellon DM, Downey JM. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev. 2003;83:1113-1151.
5. The IONA Study Group. Impact of nicorandil in angina (IONA) randomized trial. Lancet. 2002;359:1269-1275.
6. Kaneko T, Saito Y, Hirakawa Y, et al. Dose dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery. Br J Anaesth. 2001;86:332-337.
7. Suzuki K, Sawa Y, Kadoba K, et al. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. Ann Thorac Surg. 1998;65:54-58.
8. Sato T, Sasaki N, O'Rourke B, et al. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-518.
9. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33: 654-660.
10. Hayashi Y, Sawa Y, Ohtake S, et al. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass. J Cardiovasc Pharmacol. 2001;38:21-28.
11. Hackel DB, Reimer KA, Ideker RE. Comparison of enzymatic and anatomic estimates of infarct size in man. Circulation. 1984;70:824-835.
12. Katus AH, Remppis Am Looser S, et al. Enzyme linked immunoassay of cardiac troponin T for the detection of myocardial infarction in patients. J Mol Cell Cardiol. 1989;21:1349-1353.
13. Katus AH, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991; 83:902-912.
14. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
15. Knowlton AA, Apstein CS, Saouf R, et al. Leakage of heart fatty acid-binding protein with ischemia and reperfusion in rat. J Moll Cell Cardiol. 1989;21:577-583.
16. Sohmiya K, Tanaka T, Tsuji R, et al. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion-induced myocardial injury model. J Moll Cell Cardiol. 1993;25:101-115.
17. Tanaka T, Hirota Y, Sohmiya K, et al. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem. 1991;24:195-201.
18. Klein AP, Glatz JFC, Van Nieuwenhoven FAV, et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 1992;116:155-162.
19. Tsuji R, Tanaka T, Sohmiya K, et al. Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol. 1993;41:209-217.
20. Seino Y, Ogata K, Takano T, et al. Use of whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: Comparison with rapid troponin T and myoglobin tests. Am J Med. 2003; 115:185-190.
21. Nakata T, Hashimoto A, Hase M, et al. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology. 2003;99:96-104.
22. Hayashida N, Chihara S, Akasu K, et al. Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery. Jpn Circ J. 2000;64:18-22.
23. Aizawa T, Ogasawara K, Kato K. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: Comparison with nitroglycerin. J Cardiovasc Pharmacol. 1987;10(Suppl 8):S123-S129.
24. Sadaba JR, Mathew K, Munsch CM, et al. Vasorelaxant properties of nicorandil on human radial artery. Eur J Cardiothorac Surg. 2000;17: 319-324.
25. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology. 2004;100:707-721.